Actinum is a troublemaker?
By Kim JiEun | translator Choi HeeYoung
22.02.07 06:00:00
°¡³ª´Ù¶ó
0
Dongwha Pharm's contract ended on January 11
Some say that it is the cause of sluggish sales and that "Isn't it the order of withdrawal from the market?"
According to an official at Dongwha Pharm on the 14th, Actinum's sales ended in November. As of this day, the sales authority of Donghwa Pharmaceutical has expired. The problem is that domestic pharmaceutical companies that will take over the copyright of Actinum after Donghwa Pharmaceutical have not been decided, making it virtually unclear whether they will sell it in the future.
Actinum is a domestic generic of A
Kim JiEun(bob83@dailypharm.com)
If you want to see the full article, please JOIN US (click)